# Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin
> **Food and Drug Administration** · Final rule. · Published 2008-04-02 · Effective 2008-04-02 · 73 FR 17890
## Document
- **Document number:** E8-6706
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 17890
- **CFR reference:** 21 CFR 522
- **Publication date:** 2008-04-02
- **Effective date:** 2008-04-02
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare, LLC. The supplemental NADA provides for the use of enrofloxacin injectable solution in female dairy cattle less than 20 months of age.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/04/02/E8-6706/implantation-or-injectable-dosage-form-new-animal-drugs-enrofloxacin)
---
*AI Analytics · CC0 1.0*